We are live on ! Find out more
IMPV

Imperva, Inc.
IMPV

Delisted

IMPV was delisted on the 9th of January, 2019.

206 hedge funds and large institutions have $1.55B invested in Imperva, Inc. in 2018 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 70 increasing their positions, 62 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

206% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 16

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

18% more funds holding

Funds holding: 175206 (+31)

13% more capital invested

Capital invested by funds: $1.37B → $1.55B (+$178M)

13% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 62

27% less call options, than puts

Call options by funds: $3.07M | Put options by funds: $4.22M

Holders
206
Holders Change
+31
Holders Change %
+17.71%
% of All Funds
4.72%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
49
Increased
70
Reduced
62
Closed
16
Calls
$3.07M
Puts
$4.22M
Net Calls
-$1.16M
Net Calls Change
-$2.44M
Name Holding Trade Value Shares
Change
Change in
Stake
Mirae Asset Global Investments
101
Mirae Asset Global Investments
South Korea
$1.15M -$3.05K -68 -0.3%
Manulife (Manufacturers Life Insurance)
102
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.15M +$24.3K +541 +2%
LCM
103
Laurion Capital Management
New York
$1.13M +$1.17M +26,030 New
RIM
104
Redwood Investment Management
Arizona
$1.1M +$639K +14,222 +126%
DZ Bank
105
DZ Bank
Germany
$1.08M +$1.13M +25,058 New
JGC
106
J. Goldman & Co
New York
$1.06M +$1.1M +24,396 New
AIM
107
Assured Investment Management
New York
$1.04M +$1.08M +24,138 New
SO
108
STRS Ohio
Ohio
$961K
RJA
109
Raymond James & Associates
Florida
$961K +$1.12K +25 +0.1%
TP
110
Truvvo Partners
New York
$948K +$6.29K +140 +0.6%
AIG
111
American International Group
New York
$942K -$52.6K -1,171 -5%
ZIM
112
Zacks Investment Management
Illinois
$941K +$1.48K +33 +0.2%
Wellington Management Group
113
Wellington Management Group
Massachusetts
$940K +$975K +21,702 New
ARTA
114
A.R.T. Advisors
New York
$925K +$328K +7,300 +52%
UBS AM
115
UBS AM
Illinois
$919K +$266K +5,925 +39%
HJMC
116
Hellman Jordan Management Company
Massachusetts
$915K +$949K +21,135 New
TMAM
117
Tokio Marine Asset Management
Japan
$914K -$898K -20,000 -49%
PP
118
Paloma Partners
Connecticut
$885K +$918K +20,442 New
AIMCA
119
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$827K +$858K +19,100 New
Squarepoint
120
Squarepoint
New York
$792K -$212K -4,718 -21%
Balyasny Asset Management
121
Balyasny Asset Management
Illinois
$785K +$44.1K +982 +6%
Citigroup
122
Citigroup
New York
$760K -$15.9M -353,112 -95%
State Board of Administration of Florida Retirement System
123
State Board of Administration of Florida Retirement System
Florida
$751K
N
124
Nuveen
North Carolina
$695K
Barclays
125
Barclays
United Kingdom
$688K +$654K +14,566 +1,082%

IMPV Hedge Fund Activity: Q1 2018 in Review

206 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q1 2018, worth a combined $1.55B — up 13% from $1.37B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new IMPV positions and 16 closed out — a net gain of 33 holders — while 70 added to existing stakes and 62 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $29M. The largest seller was Alyeska Investment Group, cutting an estimated $38.5M.

  • 206 institutional investors held Imperva, Inc. (IMPV) as of Q1 2018, up from 175 in Q4 2017.
  • Funds reported $1.55B of Imperva, Inc. stock for Q1 2018, up 13% quarter-over-quarter.
  • 49 funds opened new Imperva, Inc. positions in Q1 2018 and 16 closed out, a net change of +33 holders.
  • The largest Imperva, Inc. buyer in Q1 2018 was Goldman Sachs, an estimated $29M added.
  • The largest Imperva, Inc. seller in Q1 2018 was Alyeska Investment Group, an estimated $38.5M sold.

Based on aggregated 13F filings for Q1 2018.